These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2079097)

  • 21. Evaluation of malignancy using Ki-67 labeling index for gastric stromal tumor.
    Nagasako Y; Misawa K; Kohashi S; Hasegawa K; Okawa Y; Sano H; Takada A; Sato H
    Gastric Cancer; 2003; 6(3):168-72. PubMed ID: 14520530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
    Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
    Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma.
    Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM
    Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ki-67 antibody labeling index in colorectal carcinoma.
    Suzuki H; Matsumoto K; Terabe M
    J Clin Gastroenterol; 1992 Dec; 15(4):317-20. PubMed ID: 1294637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer.
    Kanai T; Konno H; Maruyama K; Baba M; Tanaka T; Maruo Y; Nishino N; Nakamura S; Baba S; Sugimura H
    Eur Surg Res; 1997; 29(1):35-41. PubMed ID: 9013104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic values of proliferative markers ki-67 and repp86 in breast cancer.
    Mohsenifar J; Almassi-Aghdam M; Mohammad-Taheri Z; Zare K; Jafari B; Atri M; Mortazavi SH; Azadeh P; Bagherzadeh M; Azargashb E; Rahimi F
    Arch Iran Med; 2007 Jan; 10(1):27-31. PubMed ID: 17198450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proliferation (Ki-67 and phosphohistone H3) and oncotype DX recurrence score in estrogen receptor-positive breast cancer.
    Williams DJ; Cohen C; Darrow M; Page AJ; Chastain B; Adams AL
    Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):431-6. PubMed ID: 21297447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of proliferative rate of breast cancer by Ki-67 monoclonal antibody.
    Marchetti E; Querzoli P; Marzola A; Bagni A; Ferretti S; Fabris G; Nenci I
    Mod Pathol; 1990 Jan; 3(1):31-5. PubMed ID: 2308919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in early gastric cancer.
    Kunisaki C; Shimada H; Takahashi M; Ookubo K; Moriwaki Y; Akiyama H; Nomura M
    Hepatogastroenterology; 2001; 48(37):294-8. PubMed ID: 11268989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of T antigen expression in patients with gastric carcinoma.
    Chung YS; Yamashita Y; Kato Y; Nakata B; Sawada T; Sowa M
    Cancer; 1996 May; 77(9):1768-73. PubMed ID: 8646672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ki-67 and B72.3 expression in breast cancer: an immunohistochemical study.
    Carriero MV; Bevilacqua AM; Borrelli A; Di Bonito M; Tatangelo F; Apicella A
    Int J Rad Appl Instrum B; 1991; 18(1):95-9. PubMed ID: 2010314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of macroscopic serosal invasion in advanced gastric cancer.
    Yasuda K; Shiraishi N; Inomata M; Shiroshita H; Izumi K; Kitano S
    Hepatogastroenterology; 2007; 54(79):2028-31. PubMed ID: 18251153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of proliferative activity to survival in patients with gastric carcinoma.
    Tonemura Y; Kamata T; Ooyama S; Sugiyama K; Kimura H; Kosaka T; Yamaguchi A; Miyazaki I
    J Surg Oncol; 1990 Jan; 43(1):3-7. PubMed ID: 2296193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer.
    Mattioli E; Vogiatzi P; Sun A; Abbadessa G; Angeloni G; D'Ugo D; Trani D; Gaughan JP; Vecchio FM; Cevenini G; Persiani R; Giordano A; Claudio PP
    J Cell Physiol; 2007 Jan; 210(1):183-91. PubMed ID: 16998811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA ploidy, Ki-67 and p53 as indicators of lymph node metastasis in early gastric carcinoma.
    Sasaki O; Kido K; Nagahama S
    Anal Quant Cytol Histol; 1999 Feb; 21(1):85-8. PubMed ID: 10068782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of p53 and Ki-67 expression in resected or biopsy specimens of bile duct carcinoma.
    Murakami M; Sasaki T; Kuwada Y; Yamasaki S; Kuwahara K; Chayama K
    Oncol Rep; 2003; 10(5):1091-6. PubMed ID: 12883663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
    Lee HE; Mounajjed T; Erickson LA; Wu TT
    Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quantitative estimation of malignancy of gastric cancer by DNA ploidy and proliferative activities].
    Yonemura Y; Miyazaki I
    Rinsho Byori; 1990 Sep; 38(9):1053-8. PubMed ID: 2232266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
    Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.